Expanding indications for the use of thrombolytic agents in acute myocardial infarction
Open Access
- 1 March 1990
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 13 (S5), 53-61
- https://doi.org/10.1002/clc.4960131313
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarctionJournal of the American College of Cardiology, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)Journal of the American College of Cardiology, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.Circulation, 1987
- Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage.Circulation, 1987
- DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsEuropean Heart Journal, 1985